A004310 Stock Overview
Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical devices in South Korea and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Hyundai Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩3,745.00 |
| 52 Week High | ₩5,530.00 |
| 52 Week Low | ₩3,510.00 |
| Beta | 0 |
| 1 Month Change | -2.60% |
| 3 Month Change | -2.60% |
| 1 Year Change | -29.87% |
| 3 Year Change | -49.32% |
| 5 Year Change | -24.80% |
| Change since IPO | 340.10% |
Recent News & Updates
Recent updates
Shareholder Returns
| A004310 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -1.2% | -3.0% | -3.0% |
| 1Y | -29.9% | -0.2% | 0.6% |
Return vs Industry: A004310 underperformed the KR Pharmaceuticals industry which returned -0.2% over the past year.
Return vs Market: A004310 underperformed the KR Market which returned 0.6% over the past year.
Price Volatility
| A004310 volatility | |
|---|---|
| A004310 Average Weekly Movement | 1.7% |
| Pharmaceuticals Industry Average Movement | 4.6% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 12.0% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A004310 has not had significant price volatility in the past 3 months.
Volatility Over Time: A004310's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1965 | n/a | Young-Hak Kim | www.hyundaipharm.co.kr |
Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical devices in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antihyperlipidemic, antihypertensive, antiplatelet agent, antitussives, cell stimulants and proliferants, central nervous system, depilatory, dermatological agent, dermatology, dietary supplements, digestive system, endocrine system, expectorants, eye tonic and vitamins, gynaecolog antifungals, gynaecologic antiseptics, hemostatics, labour inhibitors, leukotriene modulator, narcotic analgesics, NSAIDs, oestrogens, ophthalmic products, OTH.sex horm and similar, SERMS, systemic hormonal contraceptives, urogenital system depilatory, uterotonic products, various alimentary tract and metabolism products, vitamins, acne, allergy, alopecia treatment, analgesics and anti-inflammatory, anemia, antimicrobial and antivirus, arthritis, contraceptives, dermatological agent, diagnostic reagent, gastrointestinal disorder and digestant, lip care, nutrition, ophthalmic product, respiratory, urogenital system, wound healing, and others. Hyundai Pharmaceutical Co., Ltd.
Hyundai Pharmaceutical Co., Ltd. Fundamentals Summary
| A004310 fundamental statistics | |
|---|---|
| Market cap | ₩102.55b |
| Earnings (TTM) | ₩1.41b |
| Revenue (TTM) | ₩108.14b |
0.0x
P/E Ratio0.0x
P/S RatioIs A004310 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A004310 income statement (TTM) | |
|---|---|
| Revenue | ₩108.14b |
| Cost of Revenue | ₩67.64b |
| Gross Profit | ₩40.49b |
| Other Expenses | ₩39.08b |
| Earnings | ₩1.41b |
Last Reported Earnings
Nov 30, 2013
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A004310 perform over the long term?
See historical performance and comparison